Latest topics
» #89 in Holistic Doctor Series Shot 5 Times In Front of Family (World Famous Healer)
Today at 7:11 pm by PurpleSkyz

» #88 Doctor Dies Unexpectedly, Holistic Prominent and Outspoken
Today at 7:08 pm by PurpleSkyz

» Bringing Awareness to Domestic Violence
Today at 6:35 pm by PurpleSkyz

Today at 6:21 pm by PurpleSkyz

» The Manipulation of Human Consciousness, Cellular Regeneration and Space-Time
Today at 5:39 pm by PurpleSkyz

» Max Igan on The Power Hour with Dr Joanne Conaway
Today at 1:47 pm by PurpleSkyz

» POOFness for APR 22: When The Ships Come In I will be at the airport eating a ketchup sandwich
Today at 1:35 pm by RamblerNash

» There Were No Commercial Plane Crashes on 9/11
Today at 11:05 am by PurpleSkyz

» The Vatican/Jesuit Satanic/Luciferian Agenda
Today at 11:05 am by Consciousness Of Economic

» The TWO Unions -- Our Dominion and Order By Anna Von Reitz
Today at 10:56 am by PurpleSkyz

» Benjamin Fulford 4-23-18
Today at 10:52 am by PurpleSkyz

Today at 10:25 am by PurpleSkyz

» UFO News ~ Black UFO Shoots Past Paddle Boarder In Waikiki, Hawaii plus MORE
Today at 10:19 am by PurpleSkyz

» The Middle East Explained - David Icke - Part Two
Today at 10:11 am by PurpleSkyz

» POOFness for APR 18: MIDWEEK BY ZAP the Lying Internet Panhandler
Today at 2:19 am by RamblerNash

» This will be Jerzy's next excuse!! LOL
Today at 2:17 am by RamblerNash

» Hey Purps...We should have a "What Will Jerzy/ZAP Beg For This Week" Poll!
Today at 2:14 am by RamblerNash

» Jerzy/ZAP And The Saga Concerning "Mary" - FOUND!
Today at 1:38 am by RamblerNash

» Office of PROOFness - Zap/Jerzy "Damage Control"
Today at 1:15 am by RamblerNash

» Out Of Mind Viewer Poll ~ "What Will Jerzy/ZAP Beg For This Week?" ~ Guests welcome to vote
Today at 12:41 am by RamblerNash

» Barrie Trower On 5G Microwaves ; There is No safe Place, No Where To Go
Yesterday at 9:18 pm by Consciousness Of Economic

Yesterday at 8:54 pm by Consciousness Of Economic


You are not connected. Please login or register

Out Of Mind » FEEL GOOD ~ BODY & MIND » CANNABIS & NATURES MEDICINALS » Why FDA Approving A Marijuana Epilepsy Drug Is Game Over For Cannabis Prohibition

Why FDA Approving A Marijuana Epilepsy Drug Is Game Over For Cannabis Prohibition

Go down  Message [Page 1 of 1]



Published on Mar 21, 2018

The FDA has approved Epidolex for epilepsy, a game changer as the FDA has approved a full cannabis medicine for those suffering from epilepsy, read this

Why FDA Approving A Marijuana Epilepsy Drug Is Game Over For Cannabis Prohibition

A Schedule 1 Drug Has No Medical Value, So Something Has To Give

Posted by DanaSmith on Tuesday Jan 30, 2018

How can the USA government argue that cannabis has no medical value, when they just approved a cannabis-based drug with evident medical value?
Cannabis-based epilepsy medicines under the name Epidiolex, manufactured by GW Pharmaceuticals, are now pending approval from the Food and Drug Administration. The drug may be available in the United States by the second half of this year.
GW Pharmaceuticals announced on Wednesday that clinical studies of the new drug came back with promising results. The study looked at 171 patients with Lennox-Gastaut syndrome who were categorized into placebo and treatment groups. The participants, aged 2 to 55, were suffering from seizures and current drugs they were taking weren’t working for them. They were taking 6 anti-seizure treatments but they were still experiencing an average of 74 drop seizures a month, a type of seizure that involves the entire body.
The results of the study, which took place over the course of 14 weeks, showed that 44% of patients who took Epidiolex showed dramatic decreases in seizures. On the other hand, only 22% of the patients in the placebo group experienced any benefits. The patients taking Epidiolex also saw a 50% or greater reduction in drop seizures. According to Elizabeth Thiele, who heads the pediatric epilepsy department at the Massachusetts General Hospital and a professor of neurology at the Harvard Medical School, the results were different on each patient. Thiele is the lead author of the study. “For some, it does not do a whole lot. But for the people it does work in, it is priceless,” she says. “One child who comes to mind had multiple seizures a day. She had been on every medication possible,” Thiele says. The said patient tried Epidiolex and hasn’t had a seizure in almost 4 years. “She is now talking about college options. She would have never had that conversation before. It has been life-changing.”
Epidiolex is made from pure cannabidiol (CBD), which has gained traction over the last few years because of its prowess in treating many chronic disorders especially conditions that conventional pharmaceutical medications have had little success in treating. One CBD product in particular, a CBD strain called Charlotte’s Web, was used to treat a child named Charlotte. Her mother, Paige Figi, began writing about this unique strain, resulting in the move of many families to Colorado state just to get their hands on the medicine. However, Charlotte’s Web remains controversial since no one has taken the responsibility of regulating the product, sales, and dosing. Charlotte’s Web in oil form was produced by a pair of brothers in Colorado, who run a small cannabis grow business.
While in essence, Charlotte’s Web and Epidiolex are the same product because they are both CBD-based extracts, Epidiolex is intended to be prescribed by doctors while the whole-plant medicine still isn’t. The FDA has also approved 2 versions of tetrahydrocannabidiol (THC), the compound in cannabis that gets you high, although these products are synthetic. If Epidiolex is approved, it would be the first plant-based cannabis drug ever to be approved by the FDA for epilepsy.
“As a pharmaceutical product, it is the subject of rigorous and intense manufacturing controls. Patients have the reassurance that the product is what we say it is and what they think it is,” says GW CEO Justin Gover, who refused to comment on pricing although says that they are already in talks with medical providers with the possibility of including it in coverage plans. Even though Epidiolex is still pending FDA approval, around 1,500 people are already using it under the FDA’s “compassionate use” program, which allows patients to use the drug on a limited time basis prior to approval.
As of now, we still don’t know if Epidiolex will have negative interactions when combined with clobazam, another widely-used anti-seizure drug. GW Pharmaceuticals’ study also still doesn’t prove that the drug will work permanently.
The FDA has until June 27, 2018 to decide if they will approve Epidiolex based on data from clinical trials. Even if it gets approved, Epidiolex could come out to be costly, but a report from the New York Times revealed that the expected costs could reach as much as $30,000-$60,000 annually.

Regardlesss, Thiele remains optimistic. “Hopefully, it will be approved,” she says. “Patients want it.”

Thanks to:


Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum